Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 7, 2015; 21(1): 196-213
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.196
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.196
Characteristic | Patients |
Gender | |
Male | 116 (67) |
Female | 56 (33) |
Age (yr) | |
≤ 50 | 73 (42) |
> 50 | 99 (58) |
Underlying liver disease | |
HBV | 133 (77) |
Others | 39 (23) |
Liver function (Child-Pugh classification) | |
Grade A | 157 (91) |
Grade B | 11 (6) |
Grade C | 4 (3) |
Preoperative AFP level | |
≤ 200 ng/mL | 66 (38) |
> 200 ng/mL | 90 (52) |
Missing data | 16 (10) |
Tumor size | |
≤ 8 cm | 116 (67) |
> 8 cm | 51 (30) |
Undetermined | 5 (3) |
Tumor number | |
≤ 3 | 157 (91) |
> 3 | 15 (9) |
Cirrhotic background | |
No | 39 (23) |
Yes | 133 (77) |
Macrovascular invasion | |
No | 149 (87) |
Yes | 23 (13) |
Tumor differentiation | |
G1/G2 | 154 (90) |
G3 | 10 (6) |
Undetermined | 8 (4) |
TNM stage | |
Stage I + II | 135 (78) |
Stage III (IIIA+IIIB+IIIC) | 37 (22) |
- Citation: Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. World J Gastroenterol 2015; 21(1): 196-213
- URL: https://www.wjgnet.com/1007-9327/full/v21/i1/196.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i1.196